JASON RICE: Open Payments
NPI 1588745863 · PAINTSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,306 in 68 payments from 23 companies in 2025. Trend: 2023 $2,044 · 2024 $1,942 · 2025 $1,306
Food & beverage: $1,306
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $216 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $167 |
| AstraZeneca Pharmaceuticals LP | 5 | $157 |
| Verona Pharma, Inc. | 5 | $101 |
| ABBVIE INC. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| SHIELD THERAPEUTICS INC | 1 | $49 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $45 |
| Lundbeck LLC | 3 | $43 |
Products named: TRELEGY ELLIPTA, Kerendia, AIRSUPRA, Ohtuvayre, REXULTI, UBRELVY, LEQVIO, ACCRUFER.
Industry payments across KY — which companies pay providers there.
